Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-04 08:53 am Sale | 2021-12-31 | 13G | Verve Therapeutics, Inc. VERV | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 1,871,679 3.890% | -623,892 (-25.00%) | Filing History |
| 2022-02-04 08:53 am Purchase | 2021-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 48,248 2.830% | 48,248 (New Position) | Filing History |
| 2021-06-28 08:50 am Purchase | 2021-06-17 | 13G | Verve Therapeutics, Inc. VERV | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 2,495,571 5.180% | 2,495,571 (New Position) | Filing History |
| 2020-10-22 10:01 am Purchase | 2020-10-12 | 13G | Aligos Therapeutics, Inc. ALGS | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 76,248 5.340% | 76,248 (New Position) | Filing |